These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38383679)

  • 41. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
    Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.
    Diez-Domingo J; Suriñach NL; Alcalde NM; Betegón L; Largeron N; Trichard M
    BMC Public Health; 2010 Aug; 10():469. PubMed ID: 20698958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Leino T; Baum U; Scott P; Ollgren J; Salo H
    Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants.
    Wu Z; Li Q; Liu Y; Lv H; Mo Z; Li F; Yu Q; Jin F; Chen W; Zhang Y; Huang T; Hu X; Xia W; Gao J; Zhou H; Bai X; Liu Y; Liang Z; Jiang Z; Chen Y; Zhang J; Du J; Yang B; Xing B; Xing Y; Dong B; Yang Q; Shi C; Yan T; Ruan B; Shi H; Fan X; Feng D; Lv W; Zhang D; Kong X; Zhou L; Que D; Chen H; Chen Z; Guo X; Zhou W; Wu C; Zhou Q; Liu Y; Qiao J; Wang Y; Li X; Duan K; Zhao Y; Xu G; Yang X
    Virol Sin; 2022 Oct; 37(5):724-730. PubMed ID: 35926726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.
    Giaquinto C; Dominiak-Felden G; Van Damme P; Myint TT; Maldonado YA; Spoulou V; Mast TC; Staat MA
    Hum Vaccin; 2011 Jul; 7(7):734-48. PubMed ID: 21734466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.
    Cheuvart B; Neuzil KM; Steele AD; Cunliffe N; Madhi SA; Karkada N; Han HH; Vinals C
    Hum Vaccin Immunother; 2014; 10(2):505-11. PubMed ID: 24240068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
    Kozawa K; Higashimoto Y; Kawamura Y; Miura H; Negishi T; Hattori F; Ihira M; Komoto S; Taniguchi K; Yoshikawa T
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037983. PubMed ID: 35240934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
    Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years: A Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies.
    Sun ZW; Fu Y; Lu HL; Yang RX; Goyal H; Jiang Y; Xu HG
    JAMA Pediatr; 2021 Jul; 175(7):e210347. PubMed ID: 33970192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness.
    Solastie A; Leino T; Ollgren J
    Vaccine; 2020 May; 38(21):3766-3772. PubMed ID: 32280041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    Ai CE; Steele M; Lopman B
    PLoS One; 2020; 15(2):e0228942. PubMed ID: 32059029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey.
    Gönüllü E; Soysal A; Yıldız İ; Karaböcüoğlu M
    Hum Vaccin Immunother; 2021 Feb; 17(2):510-516. PubMed ID: 32702249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The occurrence of severe rotavirus gastroenteritis in children under 3 years of age before and after the introduction of rotavirus vaccine: a prospective observational study in three pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Taguchi T; Nakano T; Sudo S; Kuwajima H;
    Jpn J Infect Dis; 2014; 67(4):304-6. PubMed ID: 25056079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
    Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
    Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of rotavirus vaccine on admissions due to acute gastroenteritis and rotavirus gastroenteritis in Israel.
    Klivitsky A; Algabria S; Paret G; Michaan N; Goldberg L; Halutz O; Grisaru-Soen G
    Acta Paediatr; 2021 Feb; 110(2):634-640. PubMed ID: 32654273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction.
    Myat TW; Thu HM; Tate JE; Burnett E; Cates JE; Parashar UD; Kyaw YM; Khaing TEE; Moh KM; Win NN; Khine WK; Kham MMZ; Kyaw T; Khine YY; Oo KK; Aung KM
    Vaccine; 2021 Nov; 39(47):6907-6912. PubMed ID: 34702620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.